Method for achieving desired glial growth factor 2 plasma levels

Details for Australian Patent Application No. 2009217606 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Caggiano, Anthony O.; Kim, Haesun

Agent Pizzeys

Pub. Number AU-A-2009217606

PCT Pub. Number WO2009/108390

Priority 61/067,589 29.02.08 US

Filing date 2 March 2009

Wipo publication date 3 September 2009

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/108390 Priority application(s): WO2009/108390

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217610-Monitoring of reservoir fluid moving along flow pathways in a producing oil field using passive seismic emissions

2009217599-Anchor bolt and annularly grooved expansion sleeve assembly exhibiting high pull-out resistance, particularly under cracked concrete test conditions